title: EEG changes in untreated hyperthyroidism and under the conditions of thyreostatic treatment.
abstract: 20 patients with hyperthyroidism were observed with repeated EEG measurements before and during treatment (ObsidanR; MethimazolR). 17 patients, before starting antithyroid therapy, had slight to moderate EEG abnormalities. A prevalence for moderate disturbances occurred for patients with a higher degree of hyperthyroidism. The dominant EEG frequency was higher than in euthyroid controls, but no exact correlation to T3-values could be observed. 16 patients showed abnormal reactivity to photic stimulation. One-week therapy by propranolol produced only a slight synchronizing effect in EEG's, where T3-values decreased. After 4 weeks selective therapy by MethimazolR all patients were euthyroid, but some EEG abnormalities persisted in 12 patients in a lower degree. The dominant EEG frequency decreased to control-group ranges and abnormal photic reactivity was reduced. After 6 months some EEG disturbances re-increased tentiatively, in 3 relapses excessively. These observations confirm the prognostic value of EEG measurements for the recognition of occurrence and persistence of cerebral disturbances in severe metabolic dysfunctions.
authors.affiliation: Institute of Physiology, Karl-Marx-University, College of Medicine, Leipzig/GDR.
authors.forename: H J
authors.initials: HJ
authors.lastname: Leubuscher
authors.forename: F
authors.initials: F
authors.lastname: Herrmann
authors.forename: K
authors.initials: K
authors.lastname: Hambsch
authors.forename: D
authors.initials: D
authors.lastname: Langpeter
authors.forename: P
authors.initials: P
authors.lastname: Mueller
authors.forename: D
authors.initials: D
authors.lastname: Sorger
mesh_terms: D000328:Adult; D001921:Brain / Q000503:physiopathology; D004569:Electroencephalography; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D008713:Methimazole; D011433:Propranolol